These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 15489348)

  • 1. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
    Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
    Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
    Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
    Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
    Hager WD
    Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
    Forbes GL; Drayton R; Forbes GD
    Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A; Wilson JD
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20S Proteasome as a Drug Target in Trichomonas vaginalis.
    O'Donoghue AJ; Bibo-Verdugo B; Miyamoto Y; Wang SC; Yang JZ; Zuill DE; Matsuka S; Jiang Z; Almaliti J; Caffrey CR; Gerwick WH; Eckmann L
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichomoniasis and its treatment.
    Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
    Sobel JD; Nyirjesy P; Brown W
    Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing vaginal trichomoniasis resistant to high-dose metronidazole therapy.
    Lewis DA; Habgood L; White R; Barker KF; Murphy SM
    Int J STD AIDS; 1997 Dec; 8(12):780-4. PubMed ID: 9433954
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetarsol pessaries in the treatment of metronidazole resistant Trichomonas vaginalis.
    Chen MY; Smith NA; Fox EF; Bingham JS; Barlow D
    Int J STD AIDS; 1999 Apr; 10(4):277-80. PubMed ID: 12035784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic aspects of trichomoniasis].
    Vukićević J; Jankicević J
    Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic options for the treatment of human trichomoniasis.
    Küng E; Fürnkranz U; Walochnik J
    Int J Antimicrob Agents; 2019 Feb; 53(2):116-127. PubMed ID: 30612993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
    Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
    Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of two plant extracts against vaginal trichomoniasis.
    El-Sherbini GT; El Gozamy BR; Abdel-Hady NM; Morsy TA
    J Egypt Soc Parasitol; 2009 Apr; 39(1):47-58. PubMed ID: 19530609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.
    Wendel KA; Erbelding EJ; Gaydos CA; Rompalo AM
    Clin Infect Dis; 2002 Sep; 35(5):576-80. PubMed ID: 12173132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of amixicile against T. vaginalis from clinical isolates.
    Jain E; Zaenker EI; Hoffman PS; Warren CA
    Parasitol Res; 2022 Aug; 121(8):2453-2455. PubMed ID: 35676563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects of various plants extracts on the growth of Trichomonas vaginalis.
    Sharafi SM; Yousefi M; Yousefi HA; Asghari G; Darani HY
    Infect Disord Drug Targets; 2013 Oct; 13(5):322-7. PubMed ID: 24712672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.